Kymera Therapeutics Inc (KYMR)
43.51
-0.54
(-1.23%)
USD |
NASDAQ |
Nov 21, 16:00
43.56
+0.05
(+0.11%)
Pre-Market: 20:00
Kymera Therapeutics Revenue (Quarterly): 3.741M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.741M |
| June 30, 2024 | 25.65M |
| March 31, 2024 | 10.29M |
| December 31, 2023 | 47.88M |
| September 30, 2023 | 4.728M |
| June 30, 2023 | 16.51M |
| March 31, 2023 | 9.466M |
| December 31, 2022 | 16.14M |
| September 30, 2022 | 9.551M |
| June 30, 2022 | 11.51M |
| March 31, 2022 | 9.622M |
| Date | Value |
|---|---|
| December 31, 2021 | 15.28M |
| September 30, 2021 | 20.34M |
| June 30, 2021 | 18.52M |
| March 31, 2021 | 18.70M |
| December 31, 2020 | 12.78M |
| September 30, 2020 | 14.53M |
| June 30, 2020 | 3.288M |
| March 31, 2020 | 3.428M |
| December 31, 2019 | 1.833M |
| September 30, 2019 | 0.95M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.833M
Minimum
Dec 2019
47.88M
Maximum
Dec 2023
13.69M
Average
12.15M
Median
Revenue (Quarterly) Benchmarks
| Amgen Inc | 8.503B |
| Voyager Therapeutics Inc | 24.63M |
| Denali Therapeutics Inc | -- |
| Vir Biotechnology Inc | 0.289M |
| Avidity Biosciences Inc | 2.336M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -62.49M |
| Total Expenses (Quarterly) | 75.86M |
| EPS Diluted (Quarterly) | -0.82 |
| Enterprise Value | 2.268B |
| Profit Margin (Quarterly) | -1.67K% |
| Earnings Yield | -5.38% |
| Normalized Earnings Yield | -5.218 |